In this in vivo study, HD of EBN continues to lead in upregulating levels of PGC-1α, IL-10, SOD, and downregulation of TNF-α; which will reduce the complications of metabolic syndrome (Figure 5). This evidence concerns the gene TNF and metabolic syndrome.